Philippines vs Slovenia: Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage
Philippines
59.0%
in 2024
Slovenia
56.0%
in 2024
Philippines rank
134th
Slovenia rank
137th
Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage over time
- Philippines
- Slovenia
How they compare
Philippines currently reports 59.0% against 56.0% in Slovenia, a difference of 3.0%.
That makes Philippines's figure about 1.1 times Slovenia's.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Slovenia ahead.
Philippines ranks 134th and Slovenia ranks 137th of 146 countries.
Across the 2 decades both report, Philippines averaged higher in 1 and Slovenia in 1.
Head to head by decade
| Decade | Philippines | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 41.6% | 56.0% | 14.4% | Slovenia |
| 2020s | 72.4% | 60.6% | 11.8% | Philippines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage, Philippines or Slovenia?
- Philippines, at 59.0% against 56.0% in Slovenia as of 2024.
- What is the difference in pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage between Philippines and Slovenia?
- 3.0%, with Philippines ahead.
- How many years of comparable data are there for Philippines and Slovenia?
- 10 years are reported by both, from 2015 to 2024.
- How do Philippines and Slovenia rank globally for pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage?
- Philippines ranks 134th and Slovenia ranks 137th of 146 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Pneumococcal vaccine vs. diphtheria-tetanus-pertussis vaccine coverage. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had the third dose of the pneumococcal conjugate vaccine in a given year.